Melanoma News and Research

Latest Melanoma News and Research

Researchers study relationship between MITF, ATF2 in melanoma development

Researchers study relationship between MITF, ATF2 in melanoma development

Janssen files abiraterone acetate NDS with Health Canada for metastatic, advanced prostate cancer

Janssen files abiraterone acetate NDS with Health Canada for metastatic, advanced prostate cancer

Myrexis commences Azixa controlled two-arm Phase 2b clinical study in GBM

Myrexis commences Azixa controlled two-arm Phase 2b clinical study in GBM

Researchers discover protein that suppresses melanoma progression

Researchers discover protein that suppresses melanoma progression

Delcath completes NDA submission for chemosaturation system

Delcath completes NDA submission for chemosaturation system

86.9% of adults express support for melanoma genetic testing in minors

86.9% of adults express support for melanoma genetic testing in minors

New predictive medicine product for hereditary pancreatic and related cancers

New predictive medicine product for hereditary pancreatic and related cancers

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Some cancers more prevalent in the wealthy

Some cancers more prevalent in the wealthy

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

PEG-Prom encased nanoparticle aids in cancer detection and treatment

PEG-Prom encased nanoparticle aids in cancer detection and treatment

Novel adenovirus-based gene therapy for renal cell carcinoma

Novel adenovirus-based gene therapy for renal cell carcinoma

AmoyDx receives SFDA approval for its EGFR and BRAF mutations detection kits

AmoyDx receives SFDA approval for its EGFR and BRAF mutations detection kits

Targeting mutant BRAF can kill cancer cells, but cannot finish off melanoma

Targeting mutant BRAF can kill cancer cells, but cannot finish off melanoma

CRI introduces new model of philanthropic investment to improve cancer patient care

CRI introduces new model of philanthropic investment to improve cancer patient care

Abbott initiates ABT-806 Phase 1 trial in EGFR expressing tumors

Abbott initiates ABT-806 Phase 1 trial in EGFR expressing tumors

Tolerx commences TRX518 Phase 1 trial in malignant melanoma

Tolerx commences TRX518 Phase 1 trial in malignant melanoma

Provectus commences PH-10 Phase 2c trial for psoriasis

Provectus commences PH-10 Phase 2c trial for psoriasis

Lack of strong molecular 'glue' allows tumour cells to break away and spread

Lack of strong molecular 'glue' allows tumour cells to break away and spread

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.